These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33361290)

  • 1. Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients.
    Fernández ML; Marson ME; Mastrantonio GE; Corti MA; Fleitas U; Lloveras SC; Lista N; Priarone MM; Domínguez C; Garcia-Bournissen F
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice.
    Perin L; Moreira da Silva R; Fonseca KD; Cardoso JM; Mathias FA; Reis LE; Molina I; Correa-Oliveira R; Vieira PM; Carneiro CM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
    Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
    Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient.
    Jardim E; Takayanagui OM
    J Trop Med Hyg; 1994 Dec; 97(6):367-70. PubMed ID: 7966540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi meningoencephalitis in a patient with acquired immunodeficiency syndrome.
    Yasukawa K; Patel SM; Flash CA; Stager CE; Goodman JC; Woc-Colburn L
    Am J Trop Med Hyg; 2014 Jul; 91(1):84-5. PubMed ID: 24891470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chagasic meningoencephalitis: case report of a recently included AIDS-defining illness in Brazil.
    Madalosso G; Pellini AC; Vasconcelos MJ; Ribeiro AF; Weissmann L; Oliveira Filho GS; Penalva de Oliveira AC; Vidal JE
    Rev Inst Med Trop Sao Paulo; 2004; 46(4):199-202. PubMed ID: 15361971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates.
    Bustamante JM; White BE; Wilkerson GK; Hodo CL; Auckland LD; Wang W; McCain S; Hamer SA; Saunders AB; Tarleton RL
    Antimicrob Agents Chemother; 2023 May; 67(5):e0013223. PubMed ID: 37039666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection.
    Rial MS; Scalise ML; López Alarcón M; Esteva MI; Búa J; Benatar AF; Prado NG; Riarte AR; Fichera LE
    Parasitology; 2019 Mar; 146(3):305-313. PubMed ID: 30301480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarrier-enhanced intracellular delivery of benznidazole for treatment of Trypanosoma cruzi infection.
    Li X; Yi S; Scariot DB; Martinez SJ; Falk BA; Olson CL; Romano PS; Scott EA; Engman DM
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33986194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
    Leite DI; Fontes FV; Bastos MM; Hoelz LVB; Bianco MDCAD; de Oliveira AP; da Silva PB; da Silva CF; Batista DDGJ; da Gama ANS; Peres RB; Villar JDF; Soeiro MNC; Boechat N
    Chem Biol Drug Des; 2018 Sep; 92(3):1670-1682. PubMed ID: 29745048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections?
    Dutra da Silva A; Fracasso M; Bottari NB; Gundel S; Ourique AF; Assmann CE; Ferreira DASP; Castro MFV; Reichert KP; de Souza LAF; da Veiga ML; da Rocha MIUM; Monteiro SG; Morsch VM; Chitolina Schetinger MR; da Silva AS
    Exp Parasitol; 2023 Jun; 249():108520. PubMed ID: 37001581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection.
    Nguyen DM; Poveda C; Pollet J; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011519. PubMed ID: 37988389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.
    Molina-Morant D; Fernández ML; Bosch-Nicolau P; Sulleiro E; Bangher M; Salvador F; Sanchez-Montalva A; Ribeiro ALP; de Paula AMB; Eloi S; Correa-Oliveira R; Villar JC; Sosa-Estani S; Molina I
    Trials; 2020 Apr; 21(1):328. PubMed ID: 32293523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benznidazole microcrystal preparation by solvent change precipitation and in vivo evaluation in the treatment of Chagas disease.
    Maximiano FP; de Paula LM; Figueiredo VP; de Andrade IM; Talvani A; Sá-Barreto LC; Bahia MT; Cunha-Filho MS
    Eur J Pharm Biopharm; 2011 Aug; 78(3):377-84. PubMed ID: 21397015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.
    Scalise ML; Arrúa EC; Rial MS; Esteva MI; Salomon CJ; Fichera LE
    Am J Trop Med Hyg; 2016 Aug; 95(2):388-93. PubMed ID: 27246447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benznidazole treatment of chagasic encephalitis in pregnant woman with AIDS.
    Bisio M; Altcheh J; Lattner J; Moscatelli G; Fink V; Burgos JM; Bournissen FG; Schijman AG; Freilij H
    Emerg Infect Dis; 2013; 19(9):1490-2. PubMed ID: 23965334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association.
    Diazgranados CA; Saavedra-Trujillo CH; Mantilla M; Valderrama SL; Alquichire C; Franco-Paredes C
    Lancet Infect Dis; 2009 May; 9(5):324-30. PubMed ID: 19393962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.
    Fernández ML; Marson ME; Ramirez JC; Mastrantonio G; Schijman AG; Altcheh J; Riarte AR; Bournissen FG
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):218-21. PubMed ID: 26982179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic low-dose, bi-weekly benznidazole treatment fails to prevent Trypanosoma cruzi infection in dogs under intense transmission pressure.
    Bustamante JM; Padilla AM; White B; Auckland LD; Busselman RE; Collins S; Malcolm EL; Wilson BF; Saunders AB; Hamer SA; Tarleton RL
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010688. PubMed ID: 36315597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.